191 related articles for article (PubMed ID: 11087573)
1. A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization.
Leonard KA; Hall JP; Nelen MI; Davies SR; Gollnick SO; Camacho S; Oseroff AR; Gibson SL; Hilf R; Detty MR
J Med Chem; 2000 Nov; 43(23):4488-98. PubMed ID: 11087573
[TBL] [Abstract][Full Text] [Related]
2. 2,4,6-triarylchalcogenopyrylium dyes related in structure to the antitumor agent AA1 as in vitro sensitizers for the photodynamic therapy of cancer.
Leonard KA; Nelen MI; Anderson LT; Gibson SL; Hilf R; Detty MR
J Med Chem; 1999 Sep; 42(19):3942-52. PubMed ID: 10508442
[TBL] [Abstract][Full Text] [Related]
3. In vitro photodynamic properties of chalcogenopyrylium analogues of the thiopyrylium antitumor agent AA1.
Brennan NK; Hall JP; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Detty MR
J Med Chem; 2002 Nov; 45(23):5123-35. PubMed ID: 12408723
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the dark and light-induced toxicity of thio and seleno analogues of the thiopyrylium dye AA1.
Detty MR; Gibson SL; Hilf R
Bioorg Med Chem; 2004 May; 12(10):2589-96. PubMed ID: 15110840
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of chalcogenopyrylium dyes as potential sensitizers for the photodynamic therapy of cancer.
Leonard KA; Nelen MI; Simard TP; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Chen LB; Detty MR
J Med Chem; 1999 Sep; 42(19):3953-64. PubMed ID: 10508443
[TBL] [Abstract][Full Text] [Related]
6. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.
You Y; Gibson SL; Hilf R; Davies SR; Oseroff AR; Roy I; Ohulchanskyy TY; Bergey EJ; Detty MR
J Med Chem; 2003 Aug; 46(17):3734-47. PubMed ID: 12904078
[TBL] [Abstract][Full Text] [Related]
7. Chalcogenapyrylium dyes as photochemotherapeutic agents. 2. Tumor uptake, mitochondrial targeting, and singlet-oxygen-induced inhibition of cytochrome c oxidase.
Detty MR; Merkel PB; Hilf R; Gibson SL; Powers SK
J Med Chem; 1990 Apr; 33(4):1108-16. PubMed ID: 2157006
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity.
Hilmey DG; Abe M; Nelen MI; Stilts CE; Baker GA; Baker SN; Bright FV; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Detty MR
J Med Chem; 2002 Jan; 45(2):449-61. PubMed ID: 11784149
[TBL] [Abstract][Full Text] [Related]
9. "Switched-on" flexible chalcogenopyrylium photosensitizers. Changes in photophysical properties upon binding to DNA.
Ohulchanskyy TY; Gannon MK; Ye M; Skripchenko A; Wagner SJ; Prasad PN; Detty MR
J Phys Chem B; 2007 Aug; 111(32):9686-92. PubMed ID: 17645329
[TBL] [Abstract][Full Text] [Related]
10. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells.
Cincotta L; Foley JW; Cincotta AH
Cancer Res; 1993 Jun; 53(11):2571-80. PubMed ID: 8495421
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy.
Stilts CE; Nelen MI; Hilmey DG; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Detty MR
J Med Chem; 2000 Jun; 43(12):2403-10. PubMed ID: 10882367
[TBL] [Abstract][Full Text] [Related]
12. Chalcogenapyrylium dyes as dual-action sensitizers for photodynamic therapy.
Detty MR; Merkel PB; Gibson SL; Hilf R
Oncol Res; 1992; 4(8-9):367-73. PubMed ID: 1336686
[TBL] [Abstract][Full Text] [Related]
13. Extended rhodamine photosensitizers for photodynamic therapy of cancer cells.
Davies KS; Linder MK; Kryman MW; Detty MR
Bioorg Med Chem; 2016 Sep; 24(17):3908-3917. PubMed ID: 27246858
[TBL] [Abstract][Full Text] [Related]
14. Chlorin p6-Based Water-Soluble Amino Acid Derivatives as Potent Photosensitizers for Photodynamic Therapy.
Meng Z; Yu B; Han G; Liu M; Shan B; Dong G; Miao Z; Jia N; Tan Z; Li B; Zhang W; Zhu H; Sheng C; Yao J
J Med Chem; 2016 May; 59(10):4999-5010. PubMed ID: 27136389
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial toxicity of cationic photosensitizers for photochemotherapy.
Modica-Napolitano JS; Joyal JL; Ara G; Oseroff AR; Aprille JR
Cancer Res; 1990 Dec; 50(24):7876-81. PubMed ID: 2174736
[TBL] [Abstract][Full Text] [Related]
16. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
19. Core-modified porphyrins. Part 4: Steric effects on photophysical and biological properties in vitro.
You Y; Gibson SL; Hilf R; Ohulchanskyy TY; Detty MR
Bioorg Med Chem; 2005 Mar; 13(6):2235-51. PubMed ID: 15727875
[TBL] [Abstract][Full Text] [Related]
20. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
